<DOC>
	<DOCNO>NCT02670213</DOCNO>
	<brief_summary>This study conduct Asia . Tha aim study investigate Safety Effectiveness NovoThirteen® ( rFXIII ) treatment congenital FXIII deficiency Japan .</brief_summary>
	<brief_title>A Study Safety Effectiveness NovoThirteen® ( rFXIII ) During Treatment Congenital FXIII Deficiency Japan</brief_title>
	<detailed_description />
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Male female patient , regardless age , require treatment NovoThirteenR treat physician decide use NovoThirteenR ( rFXIII ) treatment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>